Loading clinical trials...
Loading clinical trials...
A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed With Parkinson's Disease
Conditions
Interventions
CereGate Software; BSN cDBS Programmer; BSN Burst Programmer
Locations
7
United States
Kaiser Permanente, KPNC Comprehensive Movement Disorders Program
Redwood City, California, United States
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
University of Miami
Miami, Florida, United States
Northwestern University
Chicago, Illinois, United States
Wake Forest University
Winston-Salem, North Carolina, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Start Date
April 18, 2022
Primary Completion Date
June 1, 2027
Completion Date
July 1, 2027
Last Updated
February 27, 2026
NCT07187843
NCT07545473
NCT07543861
NCT05748028
NCT07495462
NCT04876339
Lead Sponsor
CereGate Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions